Water → HCID 67379216, compound
Reaction equation
Br[C:2]1[CH:3]=[C:4]([N:8]2[C:16]3[C:15]([CH3:17])=[CH:14][C:13]([CH3:18])=[CH:12][C:11]=3[C:10]3[CH2:19][N:20]([CH3:23])[CH2:21][CH2:22][C:9]2=3)[CH:5]=[CH:6][CH:7]=1.[N:24]1[CH:29]=CC(B(O)O)=[CH:26][CH:25]=1.C([O-])([O-])=O.[K+].[K+].O.CO[CH2:42][CH2:43]OC>C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH3:23][N:20]1[CH2:21][CH2:22][C:9]2[N:8]([C:4]3[CH:3]=[CH:43][CH:42]=[C:6]([C:7]4[CH:26]=[CH:25][N:24]=[CH:29][CH:2]=4)[CH:5]=3)[C:16]3[C:15]([CH3:17])=[CH:14][C:13]([CH3:18])=[CH:12][C:11]=3[C:10]=2[CH2:19]1Participants
Conditions
- Temperature
- 90 °C
Procedure
To a de-aerated solution of 5-(3-bromophenyl)-2,6,8-trimethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole (80 mg, 0.217 mmol), pyridine-4-boronic acid (53 mg, 0.431 mmol) and K2CO3 (116 mg, 0.845 mmol) in DME (4 mL)-water (2 mL) was added Pd(PPh3)4 (12 mg, 0.013 mmol). The reaction mixture was heated at 90° C. for 45 min. The reaction mixture was concentrated under reduced pressure. The residue was dissolved in EtOAc (50 mL) and washed with water (20 mL). The organic layer was dried over anhydrous sodium sulfate, concentrated under reduced pressure to obtain crude, which was purified by reverse phase HPLC to yield 2,6,8-trimethyl-5-(3-(pyridin-4-yl)phenyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole. 1H NMR (TFA salt, CD3OD) δ (ppm): 8.78 (d, 2H), 8.1 (m, 3H), 7.9 (m, 1H), 7.8 (t, 1H), 7.6 (m, 1H), 7.2 (s, 1H), 6.8 (s, 1H), 4.76 (m, 1H), 4.4 (m, 1H), 3.8 (m, 1H), 3.5 (m, 1H), 3.1 (s, 3H), 2.8-3.03 (m, 2H), 2.4 (s, 3H), 1.93 (s, 3H).
Workup
- concentrationThe reaction mixture was concentrated under reduced pressure
- dissolutionThe residue was dissolved in EtOAc (50 mL)
- washwashed with water (20 mL)
- dry with materialThe organic layer was dried over anhydrous sodium sulfate
- concentrationconcentrated under reduced pressure
- customto obtain crude, which
- customwas purified by reverse phase HPLC
Sources & evidence
- ORD record
- ord-d583d065ab55472089c6fb657e2fc097
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09199985B2
Reaction notes
Loading…